Use of tumor-derived IgG in the diagnosis or prognosis of pancreatic cancer
A technology for pancreatic ductal adenocarcinoma, which is applied in the fields of prognosis, clinical diagnosis and medicine, and can solve the problem of lack of molecular prognostic markers.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0062] The following experiments were reviewed by the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and complied with the Declaration of Helsinki. All patients were informed of the purpose of sample collection and storage in detail and signed a written consent form.
[0063] 1. Case and experimental design
[0064] A total of 326 cases of pancreatic ductal adenocarcinoma diagnosed by pathology after radical surgery were included. The pathological diagnosis and staging standards refer to the Seventh Edition of the American Cancer Society Cancer Staging Manual.
[0065] Exclusion criteria included: preoperative radiotherapy and chemotherapy, perioperative death, receiving unknown chemotherapy regimens other than gemcitabine and S1, and lack of follow-up data. Through age and gender matching, 326 cases were stratified and randomly divided into training set and validation set, both including 163 cases. Median follow-up time was 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com